Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy.
Open Access
- 1 May 1995
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 58 (5), 638-639
- https://doi.org/10.1136/jnnp.58.5.638
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Chronic systemic high‐dose recombinant interferon alfa‐2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing‐remitting multiple sclerosisNeurology, 1994
- Influence of infection on exacerbations of multiple sclerosisAnnals of Neurology, 1994
- [Interferon alpha and autoimmunity].1993
- Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)Neurology, 1991
- EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERONThe Lancet, 1987
- CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSISThe Lancet, 1985
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983